

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of hippo signaling (GO:0035330) | 7.43277916 |
| 2 | paraxial mesoderm development (GO:0048339) | 7.33290864 |
| 3 | monoubiquitinated protein deubiquitination (GO:0035520) | 6.28930680 |
| 4 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 6.05905556 |
| 5 | mitotic chromosome condensation (GO:0007076) | 5.76595330 |
| 6 | establishment of integrated proviral latency (GO:0075713) | 5.74325272 |
| 7 | notochord development (GO:0030903) | 5.73551180 |
| 8 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 5.67092789 |
| 9 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 5.67092789 |
| 10 | establishment of viral latency (GO:0019043) | 5.64786767 |
| 11 | nuclear pore complex assembly (GO:0051292) | 5.62328085 |
| 12 | regulation of spindle organization (GO:0090224) | 5.38489725 |
| 13 | gonadal mesoderm development (GO:0007506) | 5.34801622 |
| 14 | proteasome assembly (GO:0043248) | 5.29211680 |
| 15 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 5.24116934 |
| 16 | nuclear pore organization (GO:0006999) | 4.91866852 |
| 17 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.88220873 |
| 18 | synapsis (GO:0007129) | 4.86185371 |
| 19 | mitotic metaphase plate congression (GO:0007080) | 4.84448746 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.72350641 |
| 21 | carnitine shuttle (GO:0006853) | 4.70701357 |
| 22 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.66751258 |
| 23 | inner cell mass cell proliferation (GO:0001833) | 4.60719064 |
| 24 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.55078757 |
| 25 | negative regulation of ligase activity (GO:0051352) | 4.55078757 |
| 26 | mitotic nuclear envelope reassembly (GO:0007084) | 4.53343837 |
| 27 | nuclear envelope reassembly (GO:0031468) | 4.53343837 |
| 28 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.50723150 |
| 29 | cellular response to gamma radiation (GO:0071480) | 4.50040934 |
| 30 | histone lysine demethylation (GO:0070076) | 4.46917966 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.46364740 |
| 32 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.44589406 |
| 33 | regulation of mitotic spindle organization (GO:0060236) | 4.42474532 |
| 34 | regulation of translational termination (GO:0006449) | 4.41394885 |
| 35 | mitotic sister chromatid segregation (GO:0000070) | 4.35551295 |
| 36 | mitotic nuclear envelope disassembly (GO:0007077) | 4.34610176 |
| 37 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.32985349 |
| 38 | female gamete generation (GO:0007292) | 4.27918088 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.27218645 |
| 40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.27218645 |
| 41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.25527385 |
| 42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.25527385 |
| 43 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.25527385 |
| 44 | sphingosine metabolic process (GO:0006670) | 4.22889793 |
| 45 | cellular protein complex localization (GO:0034629) | 4.22674804 |
| 46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.21215109 |
| 47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.20717227 |
| 48 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.20717227 |
| 49 | histone demethylation (GO:0016577) | 4.20336320 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.17441601 |
| 51 | negative regulation of cell aging (GO:0090344) | 4.14364917 |
| 52 | pore complex assembly (GO:0046931) | 4.14018427 |
| 53 | protein maturation by protein folding (GO:0022417) | 4.11696590 |
| 54 | DNA replication checkpoint (GO:0000076) | 4.11365972 |
| 55 | membrane disassembly (GO:0030397) | 4.10667405 |
| 56 | nuclear envelope disassembly (GO:0051081) | 4.10667405 |
| 57 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.10351810 |
| 58 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.09808862 |
| 59 | corticosteroid receptor signaling pathway (GO:0031958) | 4.06817348 |
| 60 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 4.03778157 |
| 61 | microtubule depolymerization (GO:0007019) | 3.99541621 |
| 62 | DNA synthesis involved in DNA repair (GO:0000731) | 3.99396999 |
| 63 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.93444478 |
| 64 | regulation of RNA export from nucleus (GO:0046831) | 3.93263800 |
| 65 | positive regulation of ligase activity (GO:0051351) | 3.88497130 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.87862195 |
| 67 | vitamin transmembrane transport (GO:0035461) | 3.86157601 |
| 68 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.85531656 |
| 69 | protein dealkylation (GO:0008214) | 3.85103237 |
| 70 | protein demethylation (GO:0006482) | 3.85103237 |
| 71 | sister chromatid cohesion (GO:0007062) | 3.84797480 |
| 72 | fatty acid transmembrane transport (GO:1902001) | 3.81817836 |
| 73 | positive regulation of vesicle fusion (GO:0031340) | 3.80918587 |
| 74 | pentose-phosphate shunt (GO:0006098) | 3.80200509 |
| 75 | oogenesis (GO:0048477) | 3.80131337 |
| 76 | regulation of transcription elongation from RNA polymerase II promoter (GO:0034243) | 3.78173201 |
| 77 | regulation of metalloenzyme activity (GO:0048552) | 3.77636719 |
| 78 | glucose catabolic process (GO:0006007) | 3.75631395 |
| 79 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.75076383 |
| 80 | diol metabolic process (GO:0034311) | 3.73854717 |
| 81 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.73146943 |
| 82 | sister chromatid segregation (GO:0000819) | 3.69600775 |
| 83 | mitotic sister chromatid cohesion (GO:0007064) | 3.69433154 |
| 84 | histone H3-K4 methylation (GO:0051568) | 3.64844330 |
| 85 | metaphase plate congression (GO:0051310) | 3.61840079 |
| 86 | ribosomal large subunit biogenesis (GO:0042273) | 3.61260753 |
| 87 | protein complex localization (GO:0031503) | 3.57263143 |
| 88 | meiotic chromosome segregation (GO:0045132) | 3.57229612 |
| 89 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.56634967 |
| 90 | regulation of ligase activity (GO:0051340) | 3.56298798 |
| 91 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.50510843 |
| 92 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.50052886 |
| 93 | protein localization to kinetochore (GO:0034501) | 3.49296122 |
| 94 | regulation of mitochondrial translation (GO:0070129) | 3.48123567 |
| 95 | COPI coating of Golgi vesicle (GO:0048205) | 3.47462205 |
| 96 | Golgi transport vesicle coating (GO:0048200) | 3.47462205 |
| 97 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.45694628 |
| 98 | regulation of cellular amine metabolic process (GO:0033238) | 3.44487684 |
| 99 | G1 DNA damage checkpoint (GO:0044783) | 3.44335893 |
| 100 | protein retention in ER lumen (GO:0006621) | 3.42598630 |
| 101 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.42539717 |
| 102 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.42203317 |
| 103 | meiosis I (GO:0007127) | 3.41873584 |
| 104 | snRNA transcription (GO:0009301) | 3.41433838 |
| 105 | chromatin silencing (GO:0006342) | 3.40173191 |
| 106 | chromosome organization involved in meiosis (GO:0070192) | 3.39292175 |
| 107 | NADPH regeneration (GO:0006740) | 3.36970545 |
| 108 | regulation of chromatin silencing (GO:0031935) | 3.36392125 |
| 109 | ribosome assembly (GO:0042255) | 3.35304592 |
| 110 | histone H4-K12 acetylation (GO:0043983) | 3.34039387 |
| 111 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.31906938 |
| 112 | pyrimidine dimer repair (GO:0006290) | 3.30211621 |
| 113 | histone H3-K36 demethylation (GO:0070544) | 3.29184556 |
| 114 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.28977723 |
| 115 | histone H3-K9 methylation (GO:0051567) | 3.27865923 |
| 116 | pentose metabolic process (GO:0019321) | 3.27658159 |
| 117 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.26642261 |
| 118 | protein localization to chromosome, centromeric region (GO:0071459) | 3.26265987 |
| 119 | negative regulation of protein ubiquitination (GO:0031397) | 3.26153128 |
| 120 | carnitine transmembrane transport (GO:1902603) | 3.21652835 |
| 121 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.21396831 |
| 122 | purine nucleobase biosynthetic process (GO:0009113) | 3.21023289 |
| 123 | protein K6-linked ubiquitination (GO:0085020) | 3.20887935 |
| 124 | regulation of keratinocyte proliferation (GO:0010837) | 3.20251589 |
| 125 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.20041714 |
| 126 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.18977000 |
| 127 | positive regulation of cell cycle arrest (GO:0071158) | 3.18409253 |
| 128 | regulation of helicase activity (GO:0051095) | 3.16211322 |
| 129 | pre-miRNA processing (GO:0031054) | 3.16188811 |
| 130 | folic acid metabolic process (GO:0046655) | 3.14514526 |
| 131 | membrane raft organization (GO:0031579) | 3.13655907 |
| 132 | nuclear envelope organization (GO:0006998) | 3.13003487 |
| 133 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.12762336 |
| 134 | male meiosis I (GO:0007141) | 3.11107201 |
| 135 | chromosome condensation (GO:0030261) | 3.10158542 |
| 136 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.09429924 |
| 137 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.07953900 |
| 138 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.06012147 |
| 139 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.05093389 |
| 140 | DNA strand elongation (GO:0022616) | 3.02842953 |
| 141 | regulation of establishment of cell polarity (GO:2000114) | 3.01849748 |
| 142 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.01776652 |
| 143 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.98905715 |
| 144 | negative regulation of protein acetylation (GO:1901984) | 2.98825877 |
| 145 | sphingoid metabolic process (GO:0046519) | 2.97376280 |
| 146 | desmosome organization (GO:0002934) | 2.96314792 |
| 147 | growth hormone receptor signaling pathway (GO:0060396) | 2.93957460 |
| 148 | morphogenesis of an epithelial fold (GO:0060571) | 2.93390708 |
| 149 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.92391070 |
| 150 | formation of translation preinitiation complex (GO:0001731) | 2.91796775 |
| 151 | amino-acid betaine transport (GO:0015838) | 2.91419287 |
| 152 | carnitine transport (GO:0015879) | 2.91419287 |
| 153 | intracellular lipid transport (GO:0032365) | 2.90322381 |
| 154 | mitotic G1/S transition checkpoint (GO:0044819) | 2.89780310 |
| 155 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.89523579 |
| 156 | signal transduction in response to DNA damage (GO:0042770) | 2.89458681 |
| 157 | negative regulation of circadian rhythm (GO:0042754) | 2.89210199 |
| 158 | chromosome segregation (GO:0007059) | 2.87072205 |
| 159 | male meiosis (GO:0007140) | 2.86317236 |
| 160 | histone H2A monoubiquitination (GO:0035518) | 2.85261802 |
| 161 | DNA unwinding involved in DNA replication (GO:0006268) | 2.82898588 |
| 162 | negative regulation of DNA repair (GO:0045738) | 2.81511721 |
| 163 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.78923563 |
| 164 | telomere maintenance via recombination (GO:0000722) | 2.78443394 |
| 165 | pseudouridine synthesis (GO:0001522) | 2.75360264 |
| 166 | cell cycle G1/S phase transition (GO:0044843) | 2.73655880 |
| 167 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.73655880 |
| 168 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.68251747 |
| 169 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.67592563 |
| 170 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.67592563 |
| 171 | protein targeting to mitochondrion (GO:0006626) | 2.66282303 |
| 172 | pyrimidine nucleoside salvage (GO:0043097) | 2.64563472 |
| 173 | pyrimidine-containing compound salvage (GO:0008655) | 2.64563472 |
| 174 | regulation of cell cycle arrest (GO:0071156) | 2.63195349 |
| 175 | apoptotic cell clearance (GO:0043277) | 2.62677115 |
| 176 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.61447758 |
| 177 | positive regulation of protein ubiquitination (GO:0031398) | 2.60999170 |
| 178 | cellular response to interferon-alpha (GO:0035457) | 2.59705332 |
| 179 | meiotic nuclear division (GO:0007126) | 2.58806500 |
| 180 | positive regulation of actin filament depolymerization (GO:0030836) | 2.58433185 |
| 181 | hepatocyte apoptotic process (GO:0097284) | 2.57863470 |
| 182 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.57843176 |
| 183 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.57344612 |
| 184 | negative regulation of chromosome segregation (GO:0051985) | 2.57201349 |
| 185 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.57033075 |
| 186 | negative regulation of sister chromatid segregation (GO:0033046) | 2.57033075 |
| 187 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.57033075 |
| 188 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.57033075 |
| 189 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.57033075 |
| 190 | piRNA metabolic process (GO:0034587) | 2.54734409 |
| 191 | spliceosomal snRNP assembly (GO:0000387) | 2.54044205 |
| 192 | protein localization to mitochondrion (GO:0070585) | 2.52162700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.92442671 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 6.82181853 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.93222783 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.52719394 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.42071203 |
| 6 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.40304925 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.17069526 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.14834048 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.09543304 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94741253 |
| 11 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.79031243 |
| 12 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.76420454 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.74081133 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.72649988 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.67342911 |
| 16 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.58699492 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.51188817 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.46421134 |
| 19 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.40752769 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40176787 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.34165825 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.34162389 |
| 23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.33829843 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.31185685 |
| 25 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.23156846 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.22991160 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.21105057 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18245993 |
| 29 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.16672904 |
| 30 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.14278170 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12978517 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.06240479 |
| 33 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.05075601 |
| 34 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 2.05023996 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00822549 |
| 36 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.98158356 |
| 37 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.92361830 |
| 38 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.88817178 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.88733337 |
| 40 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.81222107 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.77494396 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76475915 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.76020638 |
| 44 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.72823548 |
| 45 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.67635139 |
| 46 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.65955164 |
| 47 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.63887286 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60219687 |
| 49 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.60172863 |
| 50 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.56000819 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.55884421 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53472928 |
| 53 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.52737402 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51691846 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.48925322 |
| 56 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.48925322 |
| 57 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48866776 |
| 58 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.48439821 |
| 59 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.47788591 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46125909 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45990665 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45454922 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42777857 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42074995 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40720836 |
| 66 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.39252527 |
| 67 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.37510874 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35975862 |
| 69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35958034 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.34715745 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34104527 |
| 72 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.34023789 |
| 73 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.32573862 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31727974 |
| 75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30934446 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30788890 |
| 77 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29141239 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28582024 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.27519207 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26192606 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26141187 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25958887 |
| 83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24074822 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23464271 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22797219 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20712490 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20600201 |
| 88 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19674961 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18004513 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16764461 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16435647 |
| 92 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.15405995 |
| 93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15208916 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14827498 |
| 95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14826424 |
| 96 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.14405797 |
| 97 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.13559461 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13466072 |
| 99 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12910170 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11954145 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11938850 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11280921 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11074869 |
| 104 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.10948035 |
| 105 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.10275460 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10064725 |
| 107 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09984867 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09984867 |
| 109 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08524469 |
| 110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06503036 |
| 111 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.06144290 |
| 112 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04063679 |
| 113 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02959839 |
| 114 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.02683208 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02144173 |
| 116 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.01354950 |
| 117 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01163694 |
| 118 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.97328700 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97058345 |
| 120 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96519663 |
| 121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96503128 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95876699 |
| 123 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95803176 |
| 124 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95764643 |
| 125 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95691971 |
| 126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94869594 |
| 127 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94524418 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94375836 |
| 129 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94154132 |
| 130 | MYC_22102868_ChIP-Seq_BL_Human | 0.94059098 |
| 131 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93005216 |
| 132 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92841650 |
| 133 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92570307 |
| 134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91654672 |
| 135 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91501893 |
| 136 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91307441 |
| 137 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90980905 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90354400 |
| 139 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.90255498 |
| 140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89591384 |
| 141 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87572901 |
| 142 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.86834259 |
| 143 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85006918 |
| 144 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.83106726 |
| 145 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82846959 |
| 146 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82273003 |
| 147 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81738989 |
| 148 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.81561797 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81285397 |
| 150 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81095752 |
| 151 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.80800884 |
| 152 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79225118 |
| 153 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.79048626 |
| 154 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.78812302 |
| 155 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.76438991 |
| 156 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73929420 |
| 157 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.73614834 |
| 158 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.73423258 |
| 159 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72795703 |
| 160 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72127601 |
| 161 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.71963543 |
| 162 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69632332 |
| 163 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.69599810 |
| 164 | NFYA_21822215_ChIP-Seq_K562_Human | 0.69599693 |
| 165 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.68951724 |
| 166 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67506107 |
| 167 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.67236725 |
| 168 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.66503916 |
| 169 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.66221466 |
| 170 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.65539907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.84289753 |
| 2 | MP0005451_abnormal_body_composition | 4.79059167 |
| 3 | MP0003693_abnormal_embryo_hatching | 4.23363748 |
| 4 | MP0003077_abnormal_cell_cycle | 3.65674664 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 3.57749132 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.42414058 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.30692761 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 3.28305657 |
| 9 | MP0009697_abnormal_copulation | 3.06259993 |
| 10 | MP0002653_abnormal_ependyma_morphology | 2.87127171 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.66636740 |
| 12 | MP0001346_abnormal_lacrimal_gland | 2.62678125 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.56346540 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.54540596 |
| 15 | MP0005083_abnormal_biliary_tract | 2.53612634 |
| 16 | MP0002163_abnormal_gland_morphology | 2.45467855 |
| 17 | MP0005310_abnormal_salivary_gland | 2.44336443 |
| 18 | MP0000350_abnormal_cell_proliferation | 2.37638886 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.33317283 |
| 20 | MP0001849_ear_inflammation | 2.24542130 |
| 21 | MP0001730_embryonic_growth_arrest | 2.23093958 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.21734697 |
| 23 | MP0003937_abnormal_limbs/digits/tail_de | 2.11079996 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 2.00201662 |
| 25 | MP0002160_abnormal_reproductive_system | 1.99899814 |
| 26 | MP0000566_synostosis | 1.97964092 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.86322574 |
| 28 | MP0010094_abnormal_chromosome_stability | 1.84399968 |
| 29 | MP0003718_maternal_effect | 1.79225727 |
| 30 | MP0003186_abnormal_redox_activity | 1.76720795 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.75780658 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.74759427 |
| 33 | MP0001661_extended_life_span | 1.73466225 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.68815428 |
| 35 | MP0005380_embryogenesis_phenotype | 1.68405568 |
| 36 | MP0001672_abnormal_embryogenesis/_devel | 1.68405568 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.66997928 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.61773149 |
| 39 | MP0005187_abnormal_penis_morphology | 1.60981440 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.59279069 |
| 41 | MP0000343_altered_response_to | 1.58359262 |
| 42 | MP0001697_abnormal_embryo_size | 1.57133364 |
| 43 | MP0002085_abnormal_embryonic_tissue | 1.56810165 |
| 44 | MP0005501_abnormal_skin_physiology | 1.56111542 |
| 45 | MP0010307_abnormal_tumor_latency | 1.54196924 |
| 46 | MP0000358_abnormal_cell_content/ | 1.52802886 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.52086098 |
| 48 | MP0003941_abnormal_skin_development | 1.51775804 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.50537140 |
| 50 | MP0000858_altered_metastatic_potential | 1.50203711 |
| 51 | MP0005408_hypopigmentation | 1.47911162 |
| 52 | MP0002084_abnormal_developmental_patter | 1.46579516 |
| 53 | MP0000383_abnormal_hair_follicle | 1.45613625 |
| 54 | MP0005165_increased_susceptibility_to | 1.43545877 |
| 55 | MP0008058_abnormal_DNA_repair | 1.42612817 |
| 56 | MP0005647_abnormal_sex_gland | 1.42004170 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.41519621 |
| 58 | MP0009053_abnormal_anal_canal | 1.41506857 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.39155828 |
| 60 | MP0005023_abnormal_wound_healing | 1.38299509 |
| 61 | MP0003786_premature_aging | 1.38078129 |
| 62 | MP0000762_abnormal_tongue_morphology | 1.34935813 |
| 63 | MP0002796_impaired_skin_barrier | 1.34850410 |
| 64 | MP0003984_embryonic_growth_retardation | 1.34837303 |
| 65 | MP0001853_heart_inflammation | 1.33967074 |
| 66 | MP0003938_abnormal_ear_development | 1.33552294 |
| 67 | MP0002060_abnormal_skin_morphology | 1.32987634 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.31972502 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.31726434 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.31726434 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 1.31059135 |
| 72 | MP0001929_abnormal_gametogenesis | 1.30270877 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 1.28814779 |
| 74 | MP0002210_abnormal_sex_determination | 1.26864997 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.26370473 |
| 76 | MP0000537_abnormal_urethra_morphology | 1.25134319 |
| 77 | MP0003315_abnormal_perineum_morphology | 1.24993147 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.24567914 |
| 79 | MP0001216_abnormal_epidermal_layer | 1.22390212 |
| 80 | MP0001881_abnormal_mammary_gland | 1.21695489 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 1.21041594 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.17960888 |
| 83 | MP0002006_tumorigenesis | 1.17723341 |
| 84 | MP0009278_abnormal_bone_marrow | 1.15105868 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 1.13946460 |
| 86 | MP0001119_abnormal_female_reproductive | 1.11985503 |
| 87 | MP0005330_cardiomyopathy | 1.11265185 |
| 88 | MP0005058_abnormal_lysosome_morphology | 1.10925477 |
| 89 | MP0002080_prenatal_lethality | 1.08724945 |
| 90 | MP0005623_abnormal_meninges_morphology | 1.08577712 |
| 91 | MP0000313_abnormal_cell_death | 1.06650746 |
| 92 | MP0005384_cellular_phenotype | 1.06363271 |
| 93 | MP0008260_abnormal_autophagy | 1.05327738 |
| 94 | MP0000750_abnormal_muscle_regeneration | 1.05266753 |
| 95 | MP0000427_abnormal_hair_cycle | 1.05058346 |
| 96 | MP0010771_integument_phenotype | 1.04133462 |
| 97 | MP0003868_abnormal_feces_composition | 1.03087235 |
| 98 | MP0008961_abnormal_basal_metabolism | 1.03003225 |
| 99 | MP0003119_abnormal_digestive_system | 1.01747617 |
| 100 | MP0003699_abnormal_female_reproductive | 1.01537596 |
| 101 | MP0002019_abnormal_tumor_incidence | 1.01416979 |
| 102 | MP0001915_intracranial_hemorrhage | 0.99552840 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.99320949 |
| 104 | MP0009840_abnormal_foam_cell | 0.99162542 |
| 105 | MP0002233_abnormal_nose_morphology | 0.98558753 |
| 106 | MP0004885_abnormal_endolymph | 0.97824391 |
| 107 | MP0009672_abnormal_birth_weight | 0.97365480 |
| 108 | MP0000627_abnormal_mammary_gland | 0.97305093 |
| 109 | MP0001145_abnormal_male_reproductive | 0.96270840 |
| 110 | MP0004272_abnormal_basement_membrane | 0.95915490 |
| 111 | MP0004233_abnormal_muscle_weight | 0.95647719 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.95389057 |
| 113 | MP0000653_abnormal_sex_gland | 0.94936771 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.94071455 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.93349611 |
| 116 | MP0003632_abnormal_nervous_system | 0.92094889 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.91226933 |
| 118 | MP0005395_other_phenotype | 0.89715018 |
| 119 | MP0000647_abnormal_sebaceous_gland | 0.89640081 |
| 120 | MP0000428_abnormal_craniofacial_morphol | 0.88888392 |
| 121 | MP0003755_abnormal_palate_morphology | 0.87784848 |
| 122 | MP0005164_abnormal_response_to | 0.87488732 |
| 123 | MP0000579_abnormal_nail_morphology | 0.86885954 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.86635807 |
| 125 | MP0005621_abnormal_cell_physiology | 0.86325913 |
| 126 | MP0001486_abnormal_startle_reflex | 0.85508891 |
| 127 | MP0002249_abnormal_larynx_morphology | 0.85401396 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.85176904 |
| 129 | MP0003385_abnormal_body_wall | 0.84843159 |
| 130 | MP0005389_reproductive_system_phenotype | 0.83727054 |
| 131 | MP0000613_abnormal_salivary_gland | 0.80052317 |
| 132 | MP0003935_abnormal_craniofacial_develop | 0.78385835 |
| 133 | MP0005166_decreased_susceptibility_to | 0.77084069 |
| 134 | MP0006292_abnormal_olfactory_placode | 0.76922278 |
| 135 | MP0001243_abnormal_dermal_layer | 0.75992562 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.75590476 |
| 137 | MP0003943_abnormal_hepatobiliary_system | 0.75517880 |
| 138 | MP0004197_abnormal_fetal_growth/weight/ | 0.73730193 |
| 139 | MP0002396_abnormal_hematopoietic_system | 0.73569707 |
| 140 | MP0003861_abnormal_nervous_system | 0.73433180 |
| 141 | MP0008932_abnormal_embryonic_tissue | 0.72842601 |
| 142 | MP0003828_pulmonary_edema | 0.72185762 |
| 143 | MP0000490_abnormal_crypts_of | 0.71001550 |
| 144 | MP0006035_abnormal_mitochondrial_morpho | 0.70469533 |
| 145 | MP0000432_abnormal_head_morphology | 0.69718276 |
| 146 | MP0003936_abnormal_reproductive_system | 0.69712668 |
| 147 | MP0003115_abnormal_respiratory_system | 0.67802933 |
| 148 | MP0006138_congestive_heart_failure | 0.67776332 |
| 149 | MP0003123_paternal_imprinting | 0.67358688 |
| 150 | MP0003075_altered_response_to | 0.67247414 |
| 151 | MP0002161_abnormal_fertility/fecundity | 0.67088093 |
| 152 | MP0005275_abnormal_skin_tensile | 0.66227870 |
| 153 | MP0009250_abnormal_appendicular_skeleto | 0.66183460 |
| 154 | MP0000639_abnormal_adrenal_gland | 0.66081163 |
| 155 | MP0000462_abnormal_digestive_system | 0.63421467 |
| 156 | MP0000733_abnormal_muscle_development | 0.63405345 |
| 157 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63207492 |
| 158 | MP0001851_eye_inflammation | 0.62797897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrioventricular block (HP:0001678) | 6.15442771 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 5.68022518 |
| 3 | Papillary thyroid carcinoma (HP:0002895) | 5.39633393 |
| 4 | Sparse lateral eyebrow (HP:0005338) | 5.07754118 |
| 5 | Lip pit (HP:0100267) | 4.70772830 |
| 6 | Shawl scrotum (HP:0000049) | 4.37721949 |
| 7 | Abnormality of alanine metabolism (HP:0010916) | 4.18946387 |
| 8 | Hyperalaninemia (HP:0003348) | 4.18946387 |
| 9 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.18946387 |
| 10 | Heart block (HP:0012722) | 4.07770591 |
| 11 | Breast hypoplasia (HP:0003187) | 4.06233712 |
| 12 | Abnormality of the labia minora (HP:0012880) | 3.96293389 |
| 13 | Shoulder girdle muscle weakness (HP:0003547) | 3.86625333 |
| 14 | Abnormal atrioventricular conduction (HP:0005150) | 3.80540720 |
| 15 | Urethral obstruction (HP:0000796) | 3.78841253 |
| 16 | Abnormality of the fingertips (HP:0001211) | 3.69418846 |
| 17 | Breast aplasia (HP:0100783) | 3.69064772 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.59418288 |
| 19 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.58800758 |
| 20 | Focal motor seizures (HP:0011153) | 3.57993422 |
| 21 | Ectopic kidney (HP:0000086) | 3.55403147 |
| 22 | Patellar aplasia (HP:0006443) | 3.52246316 |
| 23 | Upper limb muscle weakness (HP:0003484) | 3.45683200 |
| 24 | Anal stenosis (HP:0002025) | 3.35340839 |
| 25 | Depressed nasal tip (HP:0000437) | 3.34445100 |
| 26 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 3.30216533 |
| 27 | Sensorimotor neuropathy (HP:0007141) | 3.28099770 |
| 28 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.24913669 |
| 29 | Coarctation of aorta (HP:0001680) | 3.22267256 |
| 30 | Abnormality of glycolysis (HP:0004366) | 3.20134493 |
| 31 | Rough bone trabeculation (HP:0100670) | 3.19979031 |
| 32 | Sparse eyelashes (HP:0000653) | 3.18890655 |
| 33 | Posterior embryotoxon (HP:0000627) | 3.15699959 |
| 34 | Glucose intolerance (HP:0000833) | 3.12464814 |
| 35 | Facial hemangioma (HP:0000329) | 3.10712430 |
| 36 | Pili torti (HP:0003777) | 3.09271555 |
| 37 | Abnormal hair laboratory examination (HP:0003328) | 3.08401293 |
| 38 | Abnormality of the line of Schwalbe (HP:0008048) | 3.06233517 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 3.05801802 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.05801802 |
| 41 | Long eyelashes (HP:0000527) | 3.03722000 |
| 42 | Onycholysis (HP:0001806) | 3.00549709 |
| 43 | Abnormality of abdominal situs (HP:0011620) | 2.99085721 |
| 44 | Abdominal situs inversus (HP:0003363) | 2.99085721 |
| 45 | Abnormality of the preputium (HP:0100587) | 2.98390167 |
| 46 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.95787673 |
| 47 | Increased serum pyruvate (HP:0003542) | 2.89269281 |
| 48 | Nuclear cataract (HP:0100018) | 2.89146132 |
| 49 | High anterior hairline (HP:0009890) | 2.88761860 |
| 50 | Prominent nose (HP:0000448) | 2.86446142 |
| 51 | Adrenal hypoplasia (HP:0000835) | 2.85723771 |
| 52 | Intestinal fistula (HP:0100819) | 2.84624366 |
| 53 | Thyroid carcinoma (HP:0002890) | 2.82192296 |
| 54 | Entropion (HP:0000621) | 2.79241831 |
| 55 | Hyperacusis (HP:0010780) | 2.75945831 |
| 56 | Meckel diverticulum (HP:0002245) | 2.71749273 |
| 57 | Micronodular cirrhosis (HP:0001413) | 2.58635437 |
| 58 | Short 5th finger (HP:0009237) | 2.56822570 |
| 59 | Congenital, generalized hypertrichosis (HP:0004540) | 2.56676277 |
| 60 | Microretrognathia (HP:0000308) | 2.47147165 |
| 61 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.46270823 |
| 62 | Hepatocellular necrosis (HP:0001404) | 2.45869731 |
| 63 | Ventricular tachycardia (HP:0004756) | 2.44525546 |
| 64 | Abnormality of the ileum (HP:0001549) | 2.44348591 |
| 65 | Short nail (HP:0001799) | 2.43009087 |
| 66 | Abnormal trabecular bone morphology (HP:0100671) | 2.37370317 |
| 67 | Trismus (HP:0000211) | 2.35548285 |
| 68 | Flat capital femoral epiphysis (HP:0003370) | 2.35072086 |
| 69 | Broad face (HP:0000283) | 2.34182392 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33642226 |
| 71 | Pelvic girdle muscle weakness (HP:0003749) | 2.33516240 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33084459 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 2.33084459 |
| 74 | Abnormal glycosylation (HP:0012345) | 2.33084459 |
| 75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33084459 |
| 76 | Selective tooth agenesis (HP:0001592) | 2.32509266 |
| 77 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.32421982 |
| 78 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.30090894 |
| 79 | Hepatic necrosis (HP:0002605) | 2.29749173 |
| 80 | Abnormal pupillary function (HP:0007686) | 2.27255811 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 2.26674176 |
| 82 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.26642913 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.26463084 |
| 84 | Cholecystitis (HP:0001082) | 2.26463084 |
| 85 | Abnormality of the vocal cords (HP:0008777) | 2.26167709 |
| 86 | Anterior segment dysgenesis (HP:0007700) | 2.25751079 |
| 87 | Capillary hemangiomas (HP:0005306) | 2.25495532 |
| 88 | Ureteral stenosis (HP:0000071) | 2.25444054 |
| 89 | Hypoplastic labia majora (HP:0000059) | 2.24488260 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.24081683 |
| 91 | Esophageal atresia (HP:0002032) | 2.23769959 |
| 92 | Prostate neoplasm (HP:0100787) | 2.21085741 |
| 93 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.20779137 |
| 94 | Dry hair (HP:0011359) | 2.20194864 |
| 95 | Microglossia (HP:0000171) | 2.19986210 |
| 96 | Abnormality of chromosome stability (HP:0003220) | 2.18831689 |
| 97 | Ureteral obstruction (HP:0006000) | 2.18830713 |
| 98 | Mitochondrial inheritance (HP:0001427) | 2.18708036 |
| 99 | Squamous cell carcinoma (HP:0002860) | 2.18597470 |
| 100 | Rhabdomyolysis (HP:0003201) | 2.17805243 |
| 101 | Increased serum lactate (HP:0002151) | 2.17592057 |
| 102 | Visual hallucinations (HP:0002367) | 2.16976518 |
| 103 | Erythema (HP:0010783) | 2.16357819 |
| 104 | Deviation of the thumb (HP:0009603) | 2.16177355 |
| 105 | Acute necrotizing encephalopathy (HP:0006965) | 2.15949098 |
| 106 | Insomnia (HP:0100785) | 2.14718890 |
| 107 | Gout (HP:0001997) | 2.13782613 |
| 108 | Acute myeloid leukemia (HP:0004808) | 2.13569290 |
| 109 | Brittle hair (HP:0002299) | 2.11669846 |
| 110 | Limb-girdle muscle atrophy (HP:0003797) | 2.11053468 |
| 111 | Woolly hair (HP:0002224) | 2.10640633 |
| 112 | Increased CSF lactate (HP:0002490) | 2.10328765 |
| 113 | Myelodysplasia (HP:0002863) | 2.10232855 |
| 114 | Hypoplasia of the fovea (HP:0007750) | 2.09789862 |
| 115 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.09789862 |
| 116 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08793918 |
| 117 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08793918 |
| 118 | Progressive sensorineural hearing impairment (HP:0000408) | 2.08690096 |
| 119 | Impulsivity (HP:0100710) | 2.07111931 |
| 120 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.06808268 |
| 121 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.06808268 |
| 122 | Orthostatic hypotension (HP:0001278) | 2.05238371 |
| 123 | Proximal placement of thumb (HP:0009623) | 2.05222962 |
| 124 | Cafe-au-lait spot (HP:0000957) | 2.04472776 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 2.03896096 |
| 126 | Overlapping toe (HP:0001845) | 2.03373026 |
| 127 | Absent thumb (HP:0009777) | 2.02252180 |
| 128 | Acanthosis nigricans (HP:0000956) | 2.01682933 |
| 129 | Stenosis of the external auditory canal (HP:0000402) | 2.01411494 |
| 130 | Testicular atrophy (HP:0000029) | 2.01310280 |
| 131 | Polycythemia (HP:0001901) | 2.00999591 |
| 132 | Neoplasm of head and neck (HP:0012288) | 2.00669545 |
| 133 | Esophageal neoplasm (HP:0100751) | 2.00669545 |
| 134 | Tongue fasciculations (HP:0001308) | 1.99768537 |
| 135 | Ectropion (HP:0000656) | 1.99631755 |
| 136 | Abnormality of the labia majora (HP:0012881) | 1.99355315 |
| 137 | Hypokinesia (HP:0002375) | 1.98162252 |
| 138 | Male infertility (HP:0003251) | 1.96482715 |
| 139 | Distal lower limb amyotrophy (HP:0008944) | 1.95800829 |
| 140 | Abnormality of the carotid arteries (HP:0005344) | 1.94988758 |
| 141 | Overriding aorta (HP:0002623) | 1.94535313 |
| 142 | Progressive hearing impairment (HP:0001730) | 1.93563118 |
| 143 | Oligodactyly (HP:0012165) | 1.93187174 |
| 144 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93161728 |
| 145 | Ridged nail (HP:0001807) | 1.92636727 |
| 146 | Difficulty climbing stairs (HP:0003551) | 1.92535241 |
| 147 | Renal Fanconi syndrome (HP:0001994) | 1.92157742 |
| 148 | Heterotopia (HP:0002282) | 1.91029829 |
| 149 | Erectile abnormalities (HP:0100639) | 1.89861660 |
| 150 | Deep palmar crease (HP:0006191) | 1.89693372 |
| 151 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88746539 |
| 152 | Hemivertebrae (HP:0002937) | 1.88309175 |
| 153 | Distal lower limb muscle weakness (HP:0009053) | 1.87995102 |
| 154 | Flat cornea (HP:0007720) | 1.87824597 |
| 155 | Long palpebral fissure (HP:0000637) | 1.86520728 |
| 156 | Acute encephalopathy (HP:0006846) | 1.86392692 |
| 157 | Vertebral compression fractures (HP:0002953) | 1.86389612 |
| 158 | Renal cell carcinoma (HP:0005584) | 1.86383780 |
| 159 | Abnormality of the lower motor neuron (HP:0002366) | 1.85863093 |
| 160 | Spontaneous abortion (HP:0005268) | 1.85084229 |
| 161 | Nail dystrophy (HP:0008404) | 1.84506701 |
| 162 | Death in infancy (HP:0001522) | 1.84179737 |
| 163 | Progressive muscle weakness (HP:0003323) | 1.83902777 |
| 164 | Periauricular skin pits (HP:0100277) | 1.83237774 |
| 165 | Preauricular pit (HP:0004467) | 1.83237774 |
| 166 | Duodenal stenosis (HP:0100867) | 1.83131891 |
| 167 | Small intestinal stenosis (HP:0012848) | 1.83131891 |
| 168 | Decreased subcutaneous fat (HP:0001002) | 1.83128469 |
| 169 | Zonular cataract (HP:0010920) | 1.82730789 |
| 170 | Abnormality of cochlea (HP:0000375) | 1.82706868 |
| 171 | Short clavicles (HP:0000894) | 1.82401605 |
| 172 | Cerebral edema (HP:0002181) | 1.81084941 |
| 173 | Megalocornea (HP:0000485) | 1.81041015 |
| 174 | Tetraplegia (HP:0002445) | 1.80934767 |
| 175 | Abnormal number of erythroid precursors (HP:0012131) | 1.80683619 |
| 176 | Increased nuchal translucency (HP:0010880) | 1.80333664 |
| 177 | Abnormal glucose tolerance (HP:0001952) | 1.80198151 |
| 178 | Mask-like facies (HP:0000298) | 1.79784763 |
| 179 | Abnormality of the umbilical cord (HP:0010881) | 1.79780864 |
| 180 | Glossoptosis (HP:0000162) | 1.79606680 |
| 181 | Increased muscle lipid content (HP:0009058) | 1.78825353 |
| 182 | Achilles tendon contracture (HP:0001771) | 1.78754068 |
| 183 | Chorioretinal coloboma (HP:0000567) | 1.78725628 |
| 184 | Labial hypoplasia (HP:0000066) | 1.78711035 |
| 185 | Skin pits (HP:0100276) | 1.78647197 |
| 186 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.74854193 |
| 187 | Bradycardia (HP:0001662) | 1.72756022 |
| 188 | Ependymoma (HP:0002888) | 1.70523448 |
| 189 | Clubbing of toes (HP:0100760) | 1.70237508 |
| 190 | Hypoplastic female external genitalia (HP:0012815) | 1.69885102 |
| 191 | Peritonitis (HP:0002586) | 1.67709553 |
| 192 | Oligodactyly (hands) (HP:0001180) | 1.67703475 |
| 193 | Chromsome breakage (HP:0040012) | 1.67306014 |
| 194 | Genu recurvatum (HP:0002816) | 1.67125427 |
| 195 | Bundle branch block (HP:0011710) | 1.66141026 |
| 196 | Trigonocephaly (HP:0000243) | 1.65886489 |
| 197 | Upper motor neuron abnormality (HP:0002127) | 1.64733664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS2 | 7.32842137 |
| 2 | STK38L | 6.85059290 |
| 3 | NME2 | 5.07104326 |
| 4 | MST1R | 4.94045884 |
| 5 | VRK2 | 3.16657803 |
| 6 | STK38 | 3.06756606 |
| 7 | STK3 | 2.74022367 |
| 8 | TESK1 | 2.55780418 |
| 9 | PBK | 2.52008058 |
| 10 | MET | 2.51331847 |
| 11 | LIMK1 | 2.43649914 |
| 12 | IRAK3 | 2.43551608 |
| 13 | CDK12 | 2.24584472 |
| 14 | TESK2 | 2.19697550 |
| 15 | TAOK1 | 2.11286613 |
| 16 | TRIM28 | 2.04432616 |
| 17 | LATS1 | 10.1510833 |
| 18 | SCYL2 | 1.99953110 |
| 19 | ABL2 | 1.90192311 |
| 20 | MST4 | 1.87129581 |
| 21 | MAP3K12 | 1.85075732 |
| 22 | PAK4 | 1.81527540 |
| 23 | CDC7 | 1.80898504 |
| 24 | EIF2AK1 | 1.80461258 |
| 25 | ARAF | 1.79827521 |
| 26 | ERBB4 | 1.70931230 |
| 27 | CDK8 | 1.69770349 |
| 28 | SIK3 | 1.68278421 |
| 29 | EPHB2 | 1.61902844 |
| 30 | NEK2 | 1.59176771 |
| 31 | ZAK | 1.48929115 |
| 32 | CHEK2 | 1.45553427 |
| 33 | DYRK3 | 1.43640255 |
| 34 | PAK6 | 1.38659306 |
| 35 | ERN1 | 1.36988621 |
| 36 | BUB1 | 1.31670694 |
| 37 | CAMK1D | 1.29966838 |
| 38 | STK16 | 1.28152864 |
| 39 | BCKDK | 1.23772818 |
| 40 | EIF2AK3 | 1.21932607 |
| 41 | KSR2 | 1.21510726 |
| 42 | MAP4K2 | 1.17722705 |
| 43 | PDGFRB | 1.17341716 |
| 44 | SMG1 | 1.11135506 |
| 45 | PDK2 | 1.09750202 |
| 46 | MAP3K9 | 1.08932400 |
| 47 | RAF1 | 1.03596314 |
| 48 | BMX | 0.98666796 |
| 49 | TTK | 0.94950502 |
| 50 | NEK9 | 0.94077813 |
| 51 | PIM2 | 0.92063769 |
| 52 | TSSK6 | 0.91078563 |
| 53 | DAPK1 | 0.88843815 |
| 54 | SIK1 | 0.81906481 |
| 55 | PNCK | 0.80873807 |
| 56 | PTK2 | 0.80692469 |
| 57 | RPS6KA5 | 0.80439498 |
| 58 | KSR1 | 0.78953831 |
| 59 | SRPK1 | 0.78137003 |
| 60 | MAP3K6 | 0.76427027 |
| 61 | CDK7 | 0.76130644 |
| 62 | DAPK3 | 0.75335609 |
| 63 | LMTK2 | 0.74982177 |
| 64 | CHEK1 | 0.74569135 |
| 65 | LRRK2 | 0.72791282 |
| 66 | TLK1 | 0.64171751 |
| 67 | NEK1 | 0.63951109 |
| 68 | DDR2 | 0.63205998 |
| 69 | MAP3K3 | 0.62913601 |
| 70 | ABL1 | 0.59934460 |
| 71 | CAMK1G | 0.59522802 |
| 72 | MAP3K2 | 0.58883753 |
| 73 | ATM | 0.57639163 |
| 74 | MOS | 0.56795186 |
| 75 | PLK4 | 0.56336397 |
| 76 | ICK | 0.53492244 |
| 77 | PLK1 | 0.51806140 |
| 78 | AURKB | 0.48247524 |
| 79 | CSNK1D | 0.48124510 |
| 80 | TRIB3 | 0.47151702 |
| 81 | MAPK10 | 0.46827323 |
| 82 | MARK2 | 0.46422250 |
| 83 | MAP3K4 | 0.45989799 |
| 84 | CDK2 | 0.45573907 |
| 85 | BRSK1 | 0.44287623 |
| 86 | INSRR | 0.43033972 |
| 87 | PTK6 | 0.41987607 |
| 88 | ILK | 0.41827135 |
| 89 | CDK19 | 0.41761975 |
| 90 | MAPKAPK5 | 0.40943692 |
| 91 | WEE1 | 0.40667939 |
| 92 | CSF1R | 0.40500738 |
| 93 | CDK4 | 0.40233913 |
| 94 | TAOK2 | 0.39716122 |
| 95 | ALK | 0.39640675 |
| 96 | EIF2AK2 | 0.39287945 |
| 97 | PLK3 | 0.38068236 |
| 98 | MTOR | 0.37566268 |
| 99 | MAP3K8 | 0.36486416 |
| 100 | MAP2K1 | 0.36474680 |
| 101 | NUAK1 | 0.36471221 |
| 102 | MAPK11 | 0.35440308 |
| 103 | PRKG2 | 0.33586972 |
| 104 | STK10 | 0.33525019 |
| 105 | CSNK1G1 | 0.33001773 |
| 106 | PRKAA1 | 0.32857412 |
| 107 | MAP2K4 | 0.31935872 |
| 108 | BRSK2 | 0.31596052 |
| 109 | BCR | 0.30904182 |
| 110 | CDK1 | 0.30898927 |
| 111 | MELK | 0.30767330 |
| 112 | MARK3 | 0.30158613 |
| 113 | PRKCI | 0.29865769 |
| 114 | BRAF | 0.29447026 |
| 115 | EPHB1 | 0.28622977 |
| 116 | PRKCH | 0.28599618 |
| 117 | TAF1 | 0.28529738 |
| 118 | PTK2B | 0.28374741 |
| 119 | DMPK | 0.27912619 |
| 120 | CAMK2G | 0.27726333 |
| 121 | TBK1 | 0.27353450 |
| 122 | PRKD2 | 0.26498354 |
| 123 | STK24 | 0.26124911 |
| 124 | NME1 | 0.25711972 |
| 125 | KDR | 0.24778832 |
| 126 | VRK1 | 0.24636402 |
| 127 | DYRK1A | 0.23965064 |
| 128 | MAPKAPK2 | 0.23220963 |
| 129 | PDGFRA | 0.22939593 |
| 130 | GSK3B | 0.22298182 |
| 131 | CDK9 | 0.22167622 |
| 132 | PAK1 | 0.21363092 |
| 133 | AURKA | 0.21350997 |
| 134 | CSNK1E | 0.21296027 |
| 135 | RPS6KA4 | 0.20575980 |
| 136 | STK11 | 0.19715865 |
| 137 | EPHA2 | 0.18929358 |
| 138 | AKT2 | 0.18337175 |
| 139 | TYRO3 | 0.18177081 |
| 140 | MKNK2 | 0.17445163 |
| 141 | PAK3 | 0.17093789 |
| 142 | MAPK14 | 0.16991967 |
| 143 | MAP3K5 | 0.16182617 |
| 144 | RPS6KB2 | 0.14459429 |
| 145 | DYRK2 | 0.13473788 |
| 146 | PAK2 | 0.13204403 |
| 147 | RET | 0.12786102 |
| 148 | HCK | 0.11532236 |
| 149 | PRKAA2 | 0.11253236 |
| 150 | PIM1 | 0.10910003 |
| 151 | CSNK1G2 | 0.10435588 |
| 152 | CSNK1A1 | 0.09810132 |
| 153 | AKT1 | 0.09014787 |
| 154 | TAOK3 | 0.08042584 |
| 155 | PRKDC | 0.07580049 |
| 156 | STK4 | 0.06895130 |
| 157 | BRD4 | 0.06250229 |
| 158 | ATR | 0.06221896 |
| 159 | AKT3 | 0.05684667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 6.42769297 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.48633976 |
| 3 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 3.24243410 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.17423219 |
| 5 | RNA transport_Homo sapiens_hsa03013 | 3.15023402 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.08242079 |
| 7 | Thyroid cancer_Homo sapiens_hsa05216 | 3.03625438 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 2.99981143 |
| 9 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.86276745 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.52652534 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 2.46442050 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 2.32431961 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.20085913 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.11057360 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98262012 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.88157521 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.84502355 |
| 18 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.81826618 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75871901 |
| 20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.75743322 |
| 21 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.75704675 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.74738479 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.74090918 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.73410487 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.73002026 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71948969 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.70570680 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.63185508 |
| 29 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.59702609 |
| 30 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.54038749 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48185521 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47342492 |
| 33 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.43473860 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43269408 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41331077 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.40379747 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.40271566 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.39521627 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.36477347 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36381227 |
| 41 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.34564012 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.32343085 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31846245 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31024153 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.27803349 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27215357 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.25688897 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22024130 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20877437 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.16501816 |
| 51 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15466558 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14271667 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 1.12764692 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.12282910 |
| 55 | Melanoma_Homo sapiens_hsa05218 | 1.09094543 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 1.08548408 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07132145 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05593775 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05569322 |
| 60 | Glioma_Homo sapiens_hsa05214 | 1.04712755 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02385193 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.99502159 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97536527 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97483578 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96914161 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.95952391 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.95466302 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95429077 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94394178 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94073080 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91579085 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88490017 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88115098 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84033700 |
| 75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83030752 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.82048301 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81550711 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81055085 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79930746 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78130710 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77471255 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77426483 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76032603 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75058414 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73387938 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72925115 |
| 87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71218925 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.70739666 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65383528 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.65295086 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64414482 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63424270 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63195915 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62855794 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60471210 |
| 96 | DNA replication_Homo sapiens_hsa03030 | 0.59073961 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58805140 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58115877 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.57841764 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56328268 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55887899 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55644637 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.54594326 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52998215 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52685679 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52168411 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49900413 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49209876 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49091939 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48443357 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48380089 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48007808 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47366753 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46733467 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.46264878 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.46212676 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45179755 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44930206 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44810088 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44578443 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43518214 |
| 122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41472911 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39835281 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39445535 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38846397 |
| 126 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38304451 |
| 127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37421633 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37106505 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35871209 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35014083 |
| 131 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34292504 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33569766 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33129186 |
| 134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32330518 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32179617 |
| 136 | Mismatch repair_Homo sapiens_hsa03430 | 0.30954264 |
| 137 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30301837 |
| 138 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29905483 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29567098 |
| 140 | Legionellosis_Homo sapiens_hsa05134 | 0.28243811 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28151679 |
| 142 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27968535 |
| 143 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.27729994 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26069700 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25992752 |
| 146 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.25181638 |
| 147 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24993810 |
| 148 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23553506 |
| 149 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22210560 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21025767 |
| 151 | Influenza A_Homo sapiens_hsa05164 | 0.20343112 |
| 152 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.20116872 |
| 153 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.19648419 |
| 154 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17659636 |
| 155 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17470898 |
| 156 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12911867 |
| 157 | Lysosome_Homo sapiens_hsa04142 | 0.12830286 |
| 158 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11617928 |

